IL-17 Inhibition: A Targeted Approach to the Management of Psoriatic Arthritis
  • Program Overview
    IL-17 Inhibition: A Targeted Approach to the Management of Psoriatic Arthritis
    This program, which includes a CME-certified interactive video module, downloadable slides, and a ClinicalThought commentary, provides expert perspectives on approved and investigational IL-17–targeted therapies for treating psoriatic arthritis.
  • Featured content
    In this interactive, CME-certified video module, Dafna D. Gladman, MD, FRCPC, provides expert perspectives on approved and investigational IL-17–targeted therapies for treating psoriatic arthritis.
  • 1
  • 2

Latest Content

2 of 2 Shown
2 of 2 Shown
Show 0 More
Loading...